Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.

about

Discovery of Novel Potent Muscarinic M3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M3 Antagonists.

P2860

Q48030937-84BD06E8-28F4-4921-B9E0-24E94894DFEA

P2860

Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.

Item

http://www.wikidata.org/entity/Q38779411

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Long acting muscarinic antagon ...... current and developing drugs.

@en

type

Item

label

Long acting muscarinic antagon ...... current and developing drugs.

@en

prefLabel

Long acting muscarinic antagon ...... current and developing drugs.

@en

P1476

Long acting muscarinic antagon ...... current and developing drugs.

@en

P2093

Aaron M Mulhall

http://www.w3.org/2001/XMLSchema#string

Christopher A Droege

http://www.w3.org/2001/XMLSchema#string

Mark A Mastrodicasa

http://www.w3.org/2001/XMLSchema#string

Muhammad A Zafar

http://www.w3.org/2001/XMLSchema#string

Neil E Ernst

http://www.w3.org/2001/XMLSchema#string

Ralph J Panos

http://www.w3.org/2001/XMLSchema#string

P2860

Inositol trisphosphate and calcium signalling

Signal transduction and regulation in smooth muscle.

Muscarinic receptor antagonists: effects on pulmonary function.

Second messengers, ion channels and pharmacology of airway smooth muscle.

Tiotropium Respimat inhaler and the risk of death in COPD.

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Crosstalk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation.

Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.

Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study.

P304

161-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1276167

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28004591

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.

about

P2860

P2860

Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921